Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01952665 · ClinicalTrials.gov registry record · NA
A Multi-Center Study Comparing the Clinical Performance of Two Silicone Hydrogel Lenses Over 1 Month of Daily Wear
A NA study, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 63
- Enrollment target
NCT01952665 is a NA study that has completed, run by CooperVision. The registered enrollment target is 63 participants.
The verdict
NCT01952665, a NA study, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
Study Summary
A Multi-Center Study Comparing the Clinical Performance of Two Silicone Hydrogel Lenses Over 1 Month of Daily Wear
Interventions
- DEVICE lotrafilcon B
- DEVICE comfilcon A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2013-10 |
| Est. Completion | 2014-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01952665
The ClinicalTrials.gov registry entry for NCT01952665 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which lotrafilcon B is the first listed.
NCT01952665 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01952665 about?
NCT01952665 is a clinical study titled "A Multi-Center Study Comparing the Clinical Performance of Two Silicone Hydrogel Lenses Over 1 Month of Daily Wear". A Multi-Center Study Comparing the Clinical Performance of Two Silicone Hydrogel Lenses Over 1 Month of Daily Wear
What is the current status of trial NCT01952665?
This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2013-10. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01952665?
The interventions under investigation include: lotrafilcon B (DEVICE), comfilcon A (DEVICE).
Who is sponsoring clinical trial NCT01952665?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.